XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.820
-0.030 (-1.05%)
At close: Jul 31, 2026, 4:00 PM EDT
2.590
-0.230 (-8.16%)
After-hours: Jul 31, 2026, 4:27 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.41 million as of July 31, 2026. Its market cap has decreased by -54.49% in one year.
Market Cap
6.41M
Enterprise Value
6.33M
1-Year Change
-54.49%
Ranking
Category
Stock Price
$2.82
ChartMarket Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $6.41M, a decrease of -96.63%. That is a compound annual growth rate of -14.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.41M | -9.99% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Traws Pharma | 6.82M |
| Imunon | 6.68M |
| Kairos Pharma | 6.55M |
| Pulmatrix | 6.35M |
| Alzamend Neuro | 6.28M |
| Addex Therapeutics | 6.19M |
| Acurx Pharmaceuticals | 6.19M |
| PharmaCyte Biotech | 6.18M |